Clinical Trials Directory

Trials / Unknown

UnknownNCT02887664

The Correlation Between the n-6:n-3 Ratio and Inflammatory Markers in Small for Gestational Age (SGA) Infants Compared With Appropriate for Gestational Age (AGA) Infants

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Tel-Aviv Sourasky Medical Center · Other Government
Sex
Female
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Numerous studies have recommended the use of n-3 PUFA supplementation during human pregnancy and lactation for the prevention of preterm birth, beneficial effects on fetal development, visual and cognitive development and other functional outcomes of the infants. The aim of the present study is to assess the correlation between ratio of n-3:n-6 fatty acid and inflammation markers in SGA infants compared with appropriate for gestational age (AGA) infants. The investigators hypothesize that in SGA infants n-3 and n-6 fatty acid concentrations in cord blood will differ from those observed in AGA and might correlate with the level of circulating mediators.

Conditions

Interventions

TypeNameDescription
PROCEDUREBlood testBlood will be drawn from mother's vein and from the cord to test for n-6:n-3 ratio and inflammatory markers: CRP, IL-6, TPO and TNF-alpha markers

Timeline

Start date
2018-10-02
Primary completion
2020-12-01
Completion
2020-12-01
First posted
2016-09-02
Last updated
2019-07-18

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02887664. Inclusion in this directory is not an endorsement.